Nanoform announced that it has established Nanoform USA Inc., a wholly owned subsidiary in the U.S. This is a natural progression for the company as it continues to increase the impact of its award-winning nanonization technology and expand its major pharma client base in the US. The establishment of Nanoform USA Inc. follows the recent appointment of Sally Langa as Head of U.S. Sales. Sally brings 30 years of valuable commercial experience in Pharma, having held senior positions at Catalent Pharma, Patheon and Halo Pharmaceutical.